Skip to content

Effect of PRP injection at Jiaji point and Ashi point on postherpetic neuralgia

Effect of PRP injection at Jiaji point and Ashi point on postherpetic neuralgia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005570
Enrollment
Unknown
Registered
2022-01-31
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postherpetic neuralgia

Interventions

Control group, experimental group:PRP was injected into the muscle fascia of a shi acupoint

Sponsors

The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? Patients who met the above diagnostic criteria and still had pain 3 months after the herpes zoster lesions subsided and were excluded from pain caused by other diseases; ? The age range was 50-80 years; ? No serious systemic diseases, stable vital signs, no bleeding tendency; ? Willing to receive PRP treatment; ? No treatment was taken for PHN within 1 week; ? Patients who can read and understand by themselves.

Exclusion criteria

Exclusion criteria: ? Pregnant or lactating women; ? Patients who had used corticosteroids or immunosuppressants within one month, had severe coagulation dysfunction or were undergoing anticoagulation treatment, had severe liver and kidney dysfunction, had a history of serious cardiopulmonary diseases, and had a history of drug abuse; ? allergic constitution, or scar constitution, or infectious skin disease patients in the past; ? Inability to complete self-assessment of intelligence.

Design outcomes

Primary

MeasureTime frame
Numeric Rating Scale (NRS);

Secondary

MeasureTime frame
PSQI;DLQI;HAMD;

Countries

China

Contacts

Public ContactZhang zhongzhao
zhangzz818@163.com15286090061

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026